Small biomarker analysis finds no significant changes after 10 HBOT sessions
A Pilot Investigation of Endocannabinoid System Markers and Lipopolysaccharide Responses to 10 Sessions of Hyperbaric Oxygen Therapy.
AI Summary
This exploratory biomarker analysis asked whether repeated hyperbaric oxygen therapy (HBOT) changed circulating anandamide (AEA) or lipopolysaccharide (LPS). It used samples from 17 healthy, physically active men in a randomized parent trial: 9 received 10 HBOT sessions and 8 served as controls. The primary comparison found no significant between-group differences in changes in AEA or LPS; the analysis also found no significant differences for CB2R or FAAH, and no significant within-group changes in the HBOT participants.
As an exploratory result, baseline AEA was positively associated with baseline LPS, but that association does not show that one caused the other. This small, selected biomarker sample cannot establish that HBOT has no smaller effects or that the baseline association is reliable; confirmation in adequately powered studies is needed. This is an abstract-based summary, not a review of the full paper.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Endocannabinoid research papers you might find interesting.
Meta-analysis finds shared endocannabinoid gene changes across myopathies
Rat study finds mixed behavioral and biological effects of WIN under chronic…
Brain blood-flow reductions in acute anorexia follow a cortical hierarchy
Explore More Research
Stay informed about the latest cannabis science.